Indalo Therapeutics, a preclinical biotechnology company dedicated to developing therapies for fibrosis, is formed with an experienced team, strong IP, and robust portfolio of drug candidates.
Sector: Life Sciences
Avalyn Pharmaceuticals
Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, at the level of C3, the central protein in the complement cascade. Acquired by Biogen in 2026.
Zenflow
Zenflow is a medical device company developing the Spring Implant for patients with benign prostate hyperplasia (BPH).
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals (NASDAQ: CMPI) is a clinical stage company pursuing a novel approach to specifically activating the innate and adaptive arms of the immune system to recognize and ultimately destroy tumor cells. Checkmate Pharmaceuticals was acquired by Regeneron (NASDAQ: REGH) in 2022.
CORE Diagnostics
CORE provides high-end diagnostics services for disease stratification and therapy selection. This company was acquired in December 2024.
Promentis Pharmaceuticals
Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company, is developing innovative therapies for neuropsychiatric disorders.
Cipla Health
Cipla Health focuses on developing and commercializing products in the consumer healthcare and over-the-counter categories.
Turnstone Biologics
Turnstone Biologics (NASDAQ: TSBX) is transforming patient care with a new class of targeted viral immunotherapies to fight cancer.
Eywa Pharma
Eywa is a global generic pharmaceutical company engaged in research and development, manufacture, marketing, sale, and distribution of generic finished dosage formulations.